180 related articles for article (PubMed ID: 9184951)
1. Micronized flavonoid therapy in internal hemorrhoids of pregnancy.
Buckshee K; Takkar D; Aggarwal N
Int J Gynaecol Obstet; 1997 May; 57(2):145-51. PubMed ID: 9184951
[TBL] [Abstract][Full Text] [Related]
2. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
[TBL] [Abstract][Full Text] [Related]
3. Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial.
Giannini I; Amato A; Basso L; Tricomi N; Marranci M; Pecorella G; Tafuri S; Pennisi D; Altomare DF
Tech Coloproctol; 2015 Jun; 19(6):339-45. PubMed ID: 25893991
[TBL] [Abstract][Full Text] [Related]
4. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
La Torre F; Nicolai AP; Otti M
Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
[No Abstract] [Full Text] [Related]
5. [Common sense of diosmin administration in combined treatment of hemorrhoids].
Bashankaev BN; Wexner SD; Arkharov AV
Khirurgiia (Mosk); 2018; (8. Vyp. 2):83-89. PubMed ID: 30199057
[TBL] [Abstract][Full Text] [Related]
6. Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids: randomized controlled trial.
Ho YH; Tan M; Seow-Choen F
Dis Colon Rectum; 2000 Jan; 43(1):66-9. PubMed ID: 10813126
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic potential of micronized purified flavonoid fraction (MPFF) of diosmin and hesperidin in treatment chronic venous disorder].
Hnátek L
Vnitr Lek; 2015 Sep; 61(9):807-14. PubMed ID: 26465280
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids.
Thanapongsathorn W; Vajrabukka T
Dis Colon Rectum; 1992 Nov; 35(11):1085-8. PubMed ID: 1425054
[TBL] [Abstract][Full Text] [Related]
9. Conservative Treatment of Hemorrhoids: Results of an Observational Multicenter Study.
Zagriadskiĭ EA; Bogomazov AM; Golovko EB
Adv Ther; 2018 Nov; 35(11):1979-1992. PubMed ID: 30276625
[TBL] [Abstract][Full Text] [Related]
10. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
Amato C
Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
[TBL] [Abstract][Full Text] [Related]
11. The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes.
Jiang ZM; Cao JD
Curr Med Res Opin; 2006 Jun; 22(6):1141-7. PubMed ID: 16846547
[TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease.
Dimitroulopoulos D; Tsamakidis K; Xinopoulos D; Karaitianos I; Fotopoulou A; Paraskevas E
Clin Ther; 2005 Jun; 27(6):746-54. PubMed ID: 16117981
[TBL] [Abstract][Full Text] [Related]
13. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
Bogachev VY; Boldin BV; Turkin PY
Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
[TBL] [Abstract][Full Text] [Related]
14. Comparative Bioavailability of Two Diosmin Formulations after Oral Administration to Healthy Volunteers.
Russo R; Chandradhara D; De Tommasi N
Molecules; 2018 Aug; 23(9):. PubMed ID: 30158431
[TBL] [Abstract][Full Text] [Related]
15. Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.
Lyseng-Williamson KA; Perry CM
Drugs; 2003; 63(1):71-100. PubMed ID: 12487623
[TBL] [Abstract][Full Text] [Related]
16. Pycnogenol® in postpartum symptomatic hemorrhoids.
Belcaro G; Gizzi G; Pellegrini L; Dugall M; Luzzi R; Corsi M; Ippolito E; Ricci A; Cesarone MR; Ledda A; Bottari A; Errichi BM
Minerva Ginecol; 2014 Feb; 66(1):77-84. PubMed ID: 24569406
[TBL] [Abstract][Full Text] [Related]
17. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.
Meyer OC
Angiology; 1994 Jun; 45(6 Pt 2):579-84. PubMed ID: 8203791
[TBL] [Abstract][Full Text] [Related]
18. The fetal safety of hydrocortisone-pramoxine (Proctofoam-HC) for the treatment of hemorrhoids in late pregnancy.
Ebrahimi N; Vohra S; Gedeon C; Akoury H; Bernstein P; Pairaudeau N; Cormier J; Dontigny L; Arsenault MY; Fortin C; Goyet M; Lafortune C; Lalande J; Beauchamp C; Engel F; Fortin A; Taddio A; Einarson T; Koren G
J Obstet Gynaecol Can; 2011 Feb; 33(2):153-158. PubMed ID: 21352635
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral administration of purified micronized flavonoid fraction on increased microvascular permeability induced by various agents and on ischemia/reperfusion in the hamster cheek pouch.
Bouskela E; Donyo KA
Angiology; 1997 May; 48(5):391-9. PubMed ID: 9158383
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pycnogenol on the Healing of Venous Ulcers.
Toledo RR; Santos MERC; Schnaider TB
Ann Vasc Surg; 2017 Jan; 38():212-219. PubMed ID: 27521821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
